miR-9 secreted by tumor cells can be transferred to normal fibroblasts through exosomes, thus improving cell motility in breast cancer by reducing the expression of E-cadherin and calcium-dependent cell-cell adhesion glycoproteins [88]. This evidence concerns the gene CDH1 and neoplasm.